ArticleJournal for immunotherapy of cancer2025
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer.
Paola Bonaventura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it